Patent or proprietary medicine requires a true trade mark connection, not merely a dealer's name on ordinary descriptive labels.

Eucalyptus oil repacked and sold with labels showing the dealer's name, address, initials, and ordinary descriptive wording was not treated as a patent or proprietary medicine under Item 14-E of the First Schedule to the Central Excises and Salt Act, 1944. The explanation extending the term required a name, mark, symbol, label, or other writing used in relation to the medicine to indicate a real trade connection with a person entitled to use that mark. The Court reasoned that mere seller identification and generic descriptions such as pure eucalyptus oil or eucalyptus oil I.P. did not create the requisite commercial origin or distinctive proprietary character, so the goods did not fall within the expanded definition.

---

---

Issues: Whether eucalyptus oil repacked and sold in bottles with labels, initials, and the dealer's name fell within Item 14-E of the First Schedule to the Central Excises and Salt Act, 1944 as a patent or proprietary medicine by virtue of the explanation, and whether the use of such markings indicated a connection in the course of trade.

Analysis: The main entry did not cover eucalyptus oil, and the question turned on the explanation inserted to enlarge the meaning of patent or proprietary medicines. The oil could be treated as a drug or medicinal preparation, but that was insufficient by itself. It also had to bear a name, mark, symbol, monogram, label, signature, or other writing used in relation to the medicine so as to indicate a connection in the course of trade between the medicine and some person having a right to use that mark. The labels showed only the dealer's name, address, initials, and related descriptions such as pure eucalyptus oil and eucalyptus oil I.P. The Court held that this did not establish the kind of trade connection contemplated by the explanation. The ordinary name of eucalyptus oil and the dealer's name did not amount to a distinctive mark serving to identify the commercial origin of the goods. The construction of the explanation was also read in light of the departmental note, which indicated that the amendment was aimed at proprietary preparations marketed under special marks or brand features, not at goods bearing only the seller's name and address.

Conclusion: Eucalyptus oil so bottled and labelled did not fall within the explanation to Item 14-E and was not chargeable as a patent or proprietary medicine on that footing.

Ratio Decidendi: A medicinal preparation is not brought within the expanded definition of patent or proprietary medicine merely because it is sold under the dealer's name or with ordinary descriptive markings; the mark must be one used to indicate a real connection in the course of trade and to identify the goods as those of a particular trader.

---